AbuDhabiPR.com, Online Press Release from Dubai and Middle East

Healthcare & Fitness

  
SEHA Expands Availability of Pfizer-Biontech Covid-19 Vaccine Across Its Network of Facilities and Centers

Abu Dhabi,May 20, 2021:   Abu Dhabi Health Services Company, (SEHA), the UAE’s largest healthcare network, in collaboration with the Department of Health - Abu Dhabi, announces the availability of the Pfizer-BioNTech Covid-19 vaccine in all SEHA Covid-19 drive-through services centers and vaccination centers across the country. The Sinopharm Covid-19 vaccine continues to be available across the network’s facilities and centers. 

SEHA stands united with the UAE’s healthcare authorities and partners across the industry to ensure the community have access to vaccinations and is committed to expanding the community’s access to both vaccines. 

Both the Pfizer-BioNTech and Sinopharm Covid-19 vaccines are now being administered across 60 centers in Abu Dhabi, Dubai and the Northern Emirates. Those as young as 12 years old can receive the Pfizer-BioNTech vaccine, while the Sinopharm vaccine is only available to those over the age of 16.

Those exempt from the receiving the vaccine include those who are currently or have recently been infected with Covid-19, volunteers in Covid-19 vaccine clinical trials, pregnant women, people vaccinated outside of the country, those who have severe allergies to vaccines or vaccine components, and members of the community with diseases proven to interact negatively with the vaccine. 

Posted by : AbuDhabiPR.com Editorial Team
Viewed 29151 times
PR Category : Healthcare & Fitness
Posted on :Saturday, May 22, 2021  8:55:00 AM AUH local time (GMT+4)
Previous Article Previous Story : Bayt.com & YouGov Survey: Marketing, Healthcare, and Militar...
Next Story : SEHA Demonstrates the Value of Integration and Collaboration...Next Article

 
Most Viewed Press Release posted in the last 7 days
 

RSS Facebook Twitter LinkedDin AbuDhabiPR.com on Instagram
Back to Section Home

Related Stories
 
Top Sections
 
Top Stories